Anesthesia Local Clinical Trial
Official title:
Comparison of Combined Sciatic(Winnie's) Femoral Nerve Block, and Subarachnoid Block Anesthesia for Lower Limb Surgery
60 ASA grades- I, II or III patients, undergoing lower limb surgeries, will be randomly allocated in 2 groups of 30 patients each. In group S- subarachnoid block with 0.5% Bupivacaine (hyperbaric) 2.5ml will be given in lateral position and group B received femoral 3 in 1 block in supine position(with landmark technique) with 20 ml of 0.25% of Bupivacaine, followed by Sciatic block in lateral position with 20 ml of 0.25% Bupivacaine. Onset and duration of sensory and motor block, time of first analgesic requirement, VAS Scores at end of block and surgery, hemodynamic effects, patients' and surgeon's satisfaction will be evaluated.
After taking approval from institutional ethics committee, 60 ASA grade - I, II, III
patients will be enrolled in the study undergoing lower limb surgeries. Patients will be
randomly allocated in 2 groups of 30 patients each - Group S (spinal group) and Group B
(nerve block group). Informed consent shall be taken prior to procedure. Patients will also
be told about VAS score for pain- 0= no pain and 10= worst imaginable pain.
In the operating room, after securing 18G IV cannula, all standard monitors will be attached
(NIBP, SPO2, ECG, Temperature probe, foley's catheterization). Patients will be premedicated
with inj. Ondansetron-4mg IV stat and inj. Midazolam- 1mg IV stat in both the groups before
starting the procedure. Group S (SAB)- patients will be preloaded with 10mg/kg Ringer
lactate. Subarachnoid block in L3-L4, L4-L5 space with 0.5% Bupivacaine (Hyperbaric)-2.5ml
will be given in lateral position with involved limb in dependent position. Patient kept in
same position for 15 minutes and then turned supine. Group B (peripheral nerve block)-
femoral 3 in 1 block in supine position(with landmark technique) will be given with 20 ml of
0.25% of Bupivacaine followed by sciatic block in Labat's approach in lateral position with
20 ml of 0.25% Bupivacaine .
Sensory block will be evaluated using the pinprick test using 22-gauge hypodermic needle,
and it will be judged adequate if there will be a complete loss of pinprick sensation at T12
in the spinal group, or in the femoral and sciatic nerve distribution in the sciatic-femoral
group. Onset of Motor blockade will be taken when Bromage score 4 would have been achieved.
Bromage score 1- free movement of legs and feet; 2- just able to flex knees; 3- unable to
flex knees but free movement of feet; 4- unable to move legs or feet. VAS score would be
assessed after the procedure and surgery. Patients' vitals will be recorded before
procedure, just after the procedure and intraoperative at 5, 15 and 30 min of surgery. After
completion of surgery, hemodynamic parameters would be recorded and patient would be asked
about VAS score. After surgery, patient's and surgeon's satisfaction would also be evaluated
as 'Yes' or 'No'. Duration of analgesia will be calculated from onset of sensory blockade to
1st requirement of analgesic (VAS score >5). Injection Diclofenac- 75mg iv infusion will be
given for treatment of pain.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02593370 -
Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block
|
Phase 1 | |
Completed |
NCT02255591 -
Shamrock Versus Lumbar Ultrasound Trident - Ultrasound Guided Block of the Lumbar Plexus
|
Phase 4 |